Learn More
Medchemexpress LLC Pyrrolo[2,1-b][1,3]oxazepine-7-carboxamide, octahydro-8,8-dimethyl-4-[[(2S)-2-(methylamino)-1-oxopropyl]ami | 1422180-49-1 | MFCD34469389 | 98.4% | 456.58 g/mol | C25H36N4O4 | 5MG

Supplier: Medchemexpress LLC HY1253785MG
SBP-0636457 is a small-molecule SMAC mimetic and inhibitor of apoptosis protein (IAP) antagonist used for preclinical cancer research. It binds the BIR domains of IAP proteins (Ki = 0.27 μM) and has shown TRAIL-sensitizing activity in cell models, supporting use in both in vitro and in vivo studies.
- Binds inhibitor of apoptosis proteins with Ki of 0.27 μM.
- Demonstrated TRAIL-sensitizing activity (EC50 9 nM in MDA-MB-231 cells).
- High purity suitable for biological assays.
- Soluble in DMSO (≈45.7 mg/mL) and compatible with several in vivo formulations.
- Storage recommendations available for solid and solution forms to preserve stability.
- No cytotoxicity observed in selected breast cancer cell lines up to 20 μM.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.